Summary of Key Points Core Viewpoint - Tianchen Medical (688013) reported a closing price of 54.95 yuan on September 4, 2025, reflecting a decline of 3.87% with a turnover rate of 3.59% and a trading volume of 29,100 shares, resulting in a transaction value of 164 million yuan [1]. Trading Information Summary - On September 4, the net outflow of main funds was 21.41 million yuan, accounting for 13.09% of the total transaction value [1][3]. - The net outflow of retail funds was 574,000 yuan, representing 0.35% of the total transaction value [1]. - Retail investors saw a net inflow of 21.99 million yuan, which constituted 13.44% of the total transaction value [1]. Company Announcement Summary - Tianchen Medical plans to reappoint Gongzheng Tianye Accounting Firm (Special General Partnership) as the auditing institution for the year 2025. The firm, established in 1982, has qualifications for securities and futures-related businesses, with 349 registered accountants and 81 listed company audit clients as of the end of 2024 [1]. - The company intends to distribute a cash dividend of 5.00 yuan (including tax) for every 10 shares, based on a total share capital of 80,663,539 shares after deducting repurchased shares. The total cash dividend amounts to 40,331,769.50 yuan (including tax), which represents 83.66% of the semi-annual net profit attributable to the parent company [1][3]. - No capital reserve conversion to share capital or stock dividends will be conducted. The above proposal has been submitted for review at the third extraordinary general meeting of shareholders in 2025 [1].
股市必读:天臣医疗(688013)9月4日主力资金净流出2141.17万元,占总成交额13.09%